Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hackshaw

Showing results (51-60 of 166) with videos related to

Pageof 17
Sort By:
The Lancet. Oncology|October 31, 2009
Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trialJeffrey S Tobias, Kathryn Monson, Nirmal Gupta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 31, 2023
Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection EraEric A Klein, Sarina Madhavan, Tomasz M Beer, et al.
Journal of Hepatology|September 24, 2025
Strategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinomaEzequiel Mauro, Tiago de Castro, Marcus Zeitlhoefler, et al.
JCO Precision Oncology|January 25, 2024
Characteristics and Survival Outcomes of Patients With Metastatic <i>RET</i> Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World SettingAllan Hackshaw, Otto Fajardo, Urania Dafni, et al.
Journal of Clinical Epidemiology|April 15, 2020
The adapted Zelen was a feasible design to trial exercise in myeloma survivorsJoanne Land, Orla McCourt, Malgorzata Heinrich, et al.
JCO Precision Oncology|August 8, 2022
An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology RegistryChristophe Le Tourneau, Camille Perret, Allan Hackshaw, et al.
BJS Open|March 8, 2023
Faecal immunochemical testing for haemoglobin in detecting bowel polyps in symptomatic patients: multicentre prospective cohort studyMichael F Bath, Aman Malhi, Ruth M Ayling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancerSiow Ming Lee, Robin Rudd, Penella J Woll, et al.
Clinical Sarcoma Research|April 4, 2018
Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92Jeremy Whelan, Allan Hackshaw, Anne McTiernan, et al.
ESMO Open|August 30, 2017
Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacyAndrea Milani, Rebecca Kristeleit, Mary McCormack, et al.
Pageof 17

Showing results (51-60 of 166) with videos related to

Sort By:
Pageof 17
The Lancet. Oncology|October 31, 2009
Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trialJeffrey S Tobias, Kathryn Monson, Nirmal Gupta, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 31, 2023
Dying To Find Out: The Cost of Time at the Dawn of the Multicancer Early Detection EraEric A Klein, Sarina Madhavan, Tomasz M Beer, et al.
Journal of Hepatology|September 24, 2025
Strategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinomaEzequiel Mauro, Tiago de Castro, Marcus Zeitlhoefler, et al.
JCO Precision Oncology|January 25, 2024
Characteristics and Survival Outcomes of Patients With Metastatic <i>RET</i> Fusion-Positive Solid Tumors Receiving Non-RET Inhibitor Standards of Care in a Real-World SettingAllan Hackshaw, Otto Fajardo, Urania Dafni, et al.
Journal of Clinical Epidemiology|April 15, 2020
The adapted Zelen was a feasible design to trial exercise in myeloma survivorsJoanne Land, Orla McCourt, Malgorzata Heinrich, et al.
JCO Precision Oncology|August 8, 2022
An Approach to Solving the Complex Clinicogenomic Data Landscape in Precision Oncology: Learnings From the Design of WAYFIND-R, a Global Precision Oncology RegistryChristophe Le Tourneau, Camille Perret, Allan Hackshaw, et al.
BJS Open|March 8, 2023
Faecal immunochemical testing for haemoglobin in detecting bowel polyps in symptomatic patients: multicentre prospective cohort studyMichael F Bath, Aman Malhi, Ruth M Ayling, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancerSiow Ming Lee, Robin Rudd, Penella J Woll, et al.
Clinical Sarcoma Research|April 4, 2018
Survival is influenced by approaches to local treatment of Ewing sarcoma within an international randomised controlled trial: analysis of EICESS-92Jeremy Whelan, Allan Hackshaw, Anne McTiernan, et al.
ESMO Open|August 30, 2017
Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacyAndrea Milani, Rebecca Kristeleit, Mary McCormack, et al.
Pageof 17